These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30867508)

  • 1. Hexamethylene bisacetamide impairs NK cell-mediated clearance of acute T lymphoblastic leukemia cells and HIV-1-infected T cells that exit viral latency.
    Giuliani E; Desimio MG; Doria M
    Sci Rep; 2019 Mar; 9(1):4373. PubMed ID: 30867508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histone deacetylase inhibitor SAHA simultaneously reactivates HIV-1 from latency and up-regulates NKG2D ligands sensitizing for natural killer cell cytotoxicity.
    Desimio MG; Giuliani E; Doria M
    Virology; 2017 Oct; 510():9-21. PubMed ID: 28689087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinations of Histone Deacetylase Inhibitors with Distinct Latency Reversing Agents Variably Affect HIV Reactivation and Susceptibility to NK Cell-Mediated Killing of T Cells That Exit Viral Latency.
    Covino DA; Desimio MG; Doria M
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of the NKG2D/NKG2DL Axis in NK Cell-Mediated Clearance of the HIV-1 Reservoir.
    Desimio MG; Covino DA; Doria M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
    FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Desimio MG; Giuliani E; Ferraro AS; Adorno G; Doria M
    Front Immunol; 2018; 9():1514. PubMed ID: 30008723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing.
    Richard J; Sindhu S; Pham TN; Belzile JP; Cohen EA
    Blood; 2010 Feb; 115(7):1354-63. PubMed ID: 20008788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.
    Glässner A; Eisenhardt M; Kokordelis P; Krämer B; Wolter F; Nischalke HD; Boesecke C; Sauerbruch T; Rockstroh JK; Spengler U; Nattermann J
    J Hepatol; 2013 Sep; 59(3):427-33. PubMed ID: 23665286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells.
    Davis ZB; Sowrirajan B; Cogswell A; Ward JP; Planelles V; Barker E
    AIDS Res Hum Retroviruses; 2017 Feb; 33(2):93-100. PubMed ID: 27296670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma.
    Dupuy S; Lambert M; Zucman D; Choukem SP; Tognarelli S; Pages C; Lebbé C; Caillat-Zucman S
    PLoS Pathog; 2012 Jan; 8(1):e1002486. PubMed ID: 22253598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
    Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity.
    Satwani P; Bavishi S; Saha A; Zhao F; Ayello J; van de Ven C; Chu Y; Cairo MS
    Cytotherapy; 2014 Oct; 16(10):1431-40. PubMed ID: 24856896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
    Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
    J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of Soluble Ligands for the Activating NKG2D Receptor: One More Immune Evasion Strategy Evolved by HIV-1 ?
    Giuliani E; Vassena L; Cerboni C; Doria M
    Curr Drug Targets; 2016; 17(1):54-64. PubMed ID: 26122035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D.
    Tomescu C; Mavilio D; Montaner LJ
    AIDS; 2015 Sep; 29(14):1767-73. PubMed ID: 26372382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NKG2D functions as an activating receptor on natural killer cells in the common marmoset (Callithrix jacchus).
    Watanabe M; Kudo Y; Kawano M; Nakayama M; Nakamura K; Kameda M; Ebara M; Sato T; Nakamura M; Omine K; Kametani Y; Suzuki R; Ogasawara K
    Int Immunol; 2014 Nov; 26(11):597-606. PubMed ID: 24860119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chimeric receptor with NKG2D specificity enhances natural killer cell activation and killing of tumor cells.
    Chang YH; Connolly J; Shimasaki N; Mimura K; Kono K; Campana D
    Cancer Res; 2013 Mar; 73(6):1777-86. PubMed ID: 23302231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Natural Killer cell expression of ULBP2 is associated with a mature functional phenotype.
    Brennan K; McSharry BP; Keating S; Petrasca A; O'Reilly VP; Keane J; Doherty DG; Gardiner CM
    Hum Immunol; 2016 Oct; 77(10):876-885. PubMed ID: 27349945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells.
    Choudhary SK; Archin NM; Margolis DM
    J Infect Dis; 2008 Apr; 197(8):1162-70. PubMed ID: 18419522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NKG2D-mediated natural killer cell cytotoxicity against myeloid leukemia cells OUN-1].
    Lu XZ; Cai XH; Ma LD; Chen BA
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):444-7. PubMed ID: 22967377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.